Aceragen Inc (ACGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,545 | 36,602 | 40,590 | 44,541 | 33,229 |
| Marketable Securities | N/A | 0 | 0 | 0 | 4,499 |
| TOTAL | $34,038 | $38,299 | $43,475 | $47,018 | $41,355 |
| Non-Current Assets | |||||
| PPE Net | 22 | 27 | 33 | 38 | 44 |
| Other Non-Current Assets | 804 | 854 | 903 | 952 | 1,000 |
| TOTAL | $826 | $881 | $936 | $990 | $1,044 |
| Total Assets | $34,864 | $39,180 | $44,411 | $48,008 | $42,399 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 565 | 276 | 184 | 185 | 329 |
| Accrued Expenses | 4,088 | 5,085 | 5,645 | 4,398 | 6,072 |
| Other current liabilities | N/A | 0 | 0 | 217 | 435 |
| TOTAL | $4,862 | $5,566 | $6,029 | $4,996 | $7,027 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 549 | 603 | 656 | 708 | 126,544 |
| TOTAL | $549 | $603 | $656 | $708 | $126,544 |
| Total Liabilities | $5,411 | $6,169 | $6,685 | $5,704 | $133,571 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,112 | 3,105 | 3,102 | 2,942 | 2,485 |
| Common Shares | 3 | 53 | 52 | 46 | 38 |
| Retained earnings | -735,461 | -731,342 | -725,377 | -717,814 | -833,552 |
| TOTAL | $29,453 | $33,011 | $37,726 | $42,304 | $-91,172 |
| Total Liabilities And Equity | $34,864 | $39,180 | $44,411 | $48,008 | $42,399 |